Evidence map›Paper›PMID 41289402›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Isoform-specific regulation of PKM by acetylation.

Dariia Pavlenko, Joaquin Tamargo-Azpilicueta, Hila Nudelman, Yuval Ankri, Anat Shahar, Irene Díaz-Moreno, Eyal Arbely

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dariia PavlenkoDepartment of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Joaquin Tamargo-AzpilicuetacicCartuja, Institute for Chemical Research (IIQ), University of Seville-The Spanish National Research Council, Seville 41092, Spain.
Hila NudelmanDepartment of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Yuval AnkriDepartment of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0009-0005-0554-9929
Anat ShaharMacromolecular Crystallography Research Center, Ilse Katz Institute for Nanoscale & Science Technology, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Irene Díaz-MorenocicCartuja, Institute for Chemical Research (IIQ), University of Seville-The Spanish National Research Council, Seville 41092, Spain.ORCID 0000-0002-5318-7644
Eyal ArbelyDepartment of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0000-0002-0284-0092

Funding

EC | ERC | HORIZON EUROPE European Research Council (ERC) 678461Israel Science Foundation (ISF) 678461
6 · The paper itself

Abstract

Pyruvate kinase (PK) is a crucial glycolytic protein involved in vital cellular processes ranging from cell proliferation to immune responses. The activity and functions of PK are tightly regulated by diverse mechanisms, including posttranslational Nϵ-lysine acetylation. Although previous studies have explored the impact of acetylation on selected lysine residues within the M2 isoform of PK (PKM2), a more comprehensive selection of acetylation sites and their respective effects on both PKM2 and the highly homologous PKM1 isoform is lacking. Here, we describe the structural, functional, and regulatory effects of site-specific acetylation on an expanded set of conserved lysines in PKM2 and selected lysines in PKM1. To study homogeneously acetylated proteins, we genetically encoded the incorporation of acetylated lysine into PKM variants expressed in bacteria and cultured mammalian cells. Our integrated biochemical, structural, and computational approach revealed K115 acetylation as an inhibitory modification in both PKM1 and PKM2 that stabilizes a closed active site conformation of the proteins. We also show that, in contrast to K115 acetylation, previously reported acetylation of K305 inhibits PKM2 but has no effect on the activity and oligomerization of PKM1. These findings propose the existence of both uniform and isoform-specific regulatory mechanisms of PKM, mediated by acetylation.

Indexed as

Carrier ProteinsMembrane ProteinsPyruvate KinaseThyroid HormonesAcetylationAnimalsHEK293 CellsHumansIsoenzymesLysineProtein IsoformsProtein Processing, Post-TranslationalThyroid Hormone-Binding ProteinsCarrier ProteinsIsoenzymesLysineMembrane ProteinsProtein IsoformsPyruvate KinaseThyroid Hormone-Binding ProteinsThyroid Hormonesdeacetylationgenetic code expansionglycolysismetabolic regulationposttranslational modifications

Identifiers

PMID41289402
PMCPMC12685146

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.